Allogeneic Hematopoietic Stem Cell Transplant for People With Primary Immunodeficiency Diseases
Conditions: Lymphoproliferative Disorders; Autoimmune Lymphoproliferative; Immune System Diseases; Common Variable Immunodeficiency; Primary T-cell Immunodeficiency Disorders Interventions: Drug: Busulfan test dose; Drug: Fludarabine; Drug: Busulfan; Drug: Alemtuzumab; Radiation: Total body Irradiation; Procedure: Allogeneic HSCT; Drug: Tacrolimus (Tacro); Drug: Mycophenolate mofetil (MMF); Drug: Cyclophosphamide (Cytoxan); Other: No i ntervention Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Primary Immunodeficiency Disease | Research | Stem Cell Therapy | Stem Cells | Transplants